Fundraise / allotmentFiled on BSE ·
Unifinz Capital India Ltd announces Board meeting on Oct 15, 2026, for fund raising proposal
What the filing says
- Board meeting scheduled on October 15, 2026, at corporate office to consider preferential issuance of equity shares/share warrants or other securities subject to shareholder and regulatory approvals
- Trading window closed for all Designated Persons and relatives from October 1, 2026, until 48 hours after Q2 and H1 financial results declaration for period ending September 30, 2026
- Board may also transact any other matters with Chair's permission
Original filing
Board Meeting Intimation for Raising Of Funds.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Unifinz Capital
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentProstarm Info Systems LtdProstarm Info Systems allots 28.98 lakh convertible warrants to non-promoters
- Fundraise / allotmentSRM Contractors LtdSRM Contractors Limited informs NSE and BSE of Fund-Raising Committee meeting outcome
- Fundraise / allotmentViviana Power Tech LtdViviana Power Tech Limited Board decides against issuing fully convertible warrants
- Fundraise / allotmentVirtuoso Optoel.Virtuoso Optoelectronics Ltd allots 16.90 lakh shares on preferential basis
- Fundraise / allotmentBaazar Style Retail LtdBaazar Style Retail Limited appoints director, incorporates subsidiary, issues shares
- Fundraise / allotmentFujiyama Power Systems LtdFujiyama Power Systems Limited issues 4,11,587 equity shares under ESOP 2023
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.